Viral vectors having reduced virulence

Details Viral vectors having reduced virulence Viral vectors having reduced virulence

A - Human Necessities

61

K

A61K 48/00 (2006.01) A61K 38/00 (2006.01) C12N 7/04 (2006.01) C12N 15/63 (2006.01) C12N 15/64 (2006.01) C12N 15/863 (2006.01) C12P 21/00 (2006.01)

Patent

CA 2444743

The present invention provides recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and commprising exogenous DNA. Compositions comprising the recombinant vaccinia virus and methods of use thereof are also provided.

La présente invention concerne un virus de vaccine de recombinaison qui présente une délétion de la région codant les 7 aminoacides de la région C-terminale du produit génique E3L et comprenant de l'ADN exogène. Des compositions comprenant le virus de vaccine de recombinaison et des méthodes d'utilisation de ces dernières sont également présentées.

Affiliated with

Also associated with

Rating

Viral vectors having reduced virulence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viral vectors having reduced virulence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral vectors having reduced virulence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1842768